Purchase Order 75D30121P10351

Award Date 1/27/21
Potential Completion Date 3/27/21
Potential Value $237K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Petaluma, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a privately held company specializing in oligonucleotide-based tools. The contract, valued at $87,500.00, is for the provision of laboratory equipment. Biosearch Technologies has a history of providing laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health...
This is a firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $98,400.00. The contract, which has no set-aside designation, is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like influenza, COVID-19, Ebola, and...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), to Biosearch Technologies, Inc. (dba Biosearch Technologies). The $473,206.40 contract is for the provision of a SARS-COV-2 Influenza Multiplex Assay, which supports disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as COVID-19. Biosearch Technologies,...
This is a federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately-held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. The contract, awarded by the Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services, is an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a potential value of $145,400.00. It is a firm fixed price contract with no...
This is a federal contract award to Biosearch Technologies, Inc. (Biosearch) by the Centers for Disease Control and Prevention (CDC) under the BIOSEARCH IDIQ (Indefinite Delivery/Indefinite Quantity) contract vehicle. The contract, valued at $677,800.00, is for the delivery of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order to Biosearch Technologies, Inc. for the procurement of 20 Signature polymerase chain reaction (PCR) kits. The award, valued at $242,150.00, leveraged Biosearch Technologies' unique Black Hole Quencher technology, which is required for the production of these PCR reagents and is only licensed by Biosearch. This sole-source award was made under the...
This federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately held manufacturer of oligonucleotide-based tools, is for the provision of primers and probes. The $127,000.00 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as influenza, COVID-19, Ebola, and Brucella....
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $164,625.00. The contract is for the delivery of laboratory kits, with no set-aside designation. Biosearch Technologies, through its LGC Biosearch Technologies division, has provided a variety of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC's public health research...
The Centers for Disease Control and Prevention (CDC) awarded a $1,343,205.50 firm fixed-price contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division to provide primer probes. This award was not set aside for any specific business type. Biosearch Technologies has a history of providing laboratory supplies like assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts for federal...

This is a $236,603.20 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC), which is part of the Department of Health and Human Services, to Biosearch Technologies, Inc. The award is for the provision of RUO (Research Use Only) oligonucleotides. Biosearch Technologies is a manufacturer of oligonucleotide-based tools, including fluorophores and dark quenchers, and has previously provided laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National Institutes of Health in disease surveillance, diagnostic testing, public health research, and emergency response efforts. The contract does not have a set-aside designation.

Generated 3/22/24, 12:15 PM